Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladislav Pecen

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyPetr Zatloukal, Lubos Petruzelka, Milada Zemanova, et al.
Plos One|November 8, 2014
Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatmentVladimir Koblizek, Ladislav Pecen, Jaromir Zatloukal, et al.
BMC Medicine|November 5, 2019
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroupsGeorg Gelbenegger, Marek Postula, Ladislav Pecen, et al.
Anticancer Research|August 9, 2015
PHI in the Early Detection of Prostate CancerRadka Fuchsova, Ondrej Topolcan, Jindra Windrichova, et al.
European Journal of Radiology|March 3, 2021
Computed tomography with a full FOV photon-counting detector in a clinical setting, the first experienceJiří Ferda, Tomáš Vendiš, Thomas Flohr, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2009
FXa inhibition and coagulation changes during DVT prophylaxis by enoxaparin over the course of a 15-day follow-up in septic patientsZuzana Zenáhlíková, Jan Kvasnicka, Zuzana Kudrnová, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2021
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation RegistriesMiklos Rohla, Ladislav Pecen, Roberto Cemin, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Long-Term Monitoring of the Antibody Response to a SARS-CoV-2 InfectionVáclav Šimánek, Ladislav Pecen, Hana Řezáčková, et al.
Melanoma Research|July 22, 2005
KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patientsFilip Janku, Jan Novotny, Ivan Julis, et al.
The American Journal of Medicine|January 22, 2019
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyPetr Zatloukal, Lubos Petruzelka, Milada Zemanova, et al.
Plos One|November 8, 2014
Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatmentVladimir Koblizek, Ladislav Pecen, Jaromir Zatloukal, et al.
BMC Medicine|November 5, 2019
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroupsGeorg Gelbenegger, Marek Postula, Ladislav Pecen, et al.
Anticancer Research|August 9, 2015
PHI in the Early Detection of Prostate CancerRadka Fuchsova, Ondrej Topolcan, Jindra Windrichova, et al.
European Journal of Radiology|March 3, 2021
Computed tomography with a full FOV photon-counting detector in a clinical setting, the first experienceJiří Ferda, Tomáš Vendiš, Thomas Flohr, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2009
FXa inhibition and coagulation changes during DVT prophylaxis by enoxaparin over the course of a 15-day follow-up in septic patientsZuzana Zenáhlíková, Jan Kvasnicka, Zuzana Kudrnová, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2021
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation RegistriesMiklos Rohla, Ladislav Pecen, Roberto Cemin, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Long-Term Monitoring of the Antibody Response to a SARS-CoV-2 InfectionVáclav Šimánek, Ladislav Pecen, Hana Řezáčková, et al.
Melanoma Research|July 22, 2005
KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patientsFilip Janku, Jan Novotny, Ivan Julis, et al.
The American Journal of Medicine|January 22, 2019
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Pageof 9